Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Harvard Business School
Baxter
Express Scripts
Mallinckrodt

Last Updated: August 15, 2022

Investigational Drug Information for Aramchol


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Aramchol?

Aramchol is an investigational drug.

There have been 11 clinical trials for Aramchol. The most recent clinical trial was a Phase 2 trial, which was initiated on September 23rd 2019.

The most common disease conditions in clinical trials are Liver Diseases, Fatty Liver, and Non-alcoholic Fatty Liver Disease. The leading clinical trial sponsors are Galmed Pharmaceuticals Ltd, Diamond Pharma Services Regulatory Affairs Consultancy, and Galmed Research and Development, Ltd.

There are forty-eight US patents protecting this investigational drug and seven hundred and thirteen international patents.

Recent Clinical Trials for Aramchol
TitleSponsorPhase
Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic ImpairmentGalmed Research and Development, Ltd.Phase 1
A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)Galmed Research and Development, Ltd.Phase 3
Comparison of Aramchol Concentrations With Once or Twice Daily DosingAnalyst Research LaboratoriesPhase 1

See all Aramchol clinical trials

Clinical Trial Summary for Aramchol

Top disease conditions for Aramchol
Top clinical trial sponsors for Aramchol

See all Aramchol clinical trials

US Patents for Aramchol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Aramchol See Plans and Pricing Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists Bristol-Myers Squibb Company (Princeton, NJ) Syngene International Limited (Bangalore, Karnataka, IN) See Plans and Pricing
Aramchol See Plans and Pricing Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) See Plans and Pricing
Aramchol See Plans and Pricing Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Pfizer Inc. (New York, NY) See Plans and Pricing
Aramchol See Plans and Pricing Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof Gilead Apollo, LLC (Foster City, CA) See Plans and Pricing
Aramchol See Plans and Pricing GLP-1 receptor agonists and uses thereof Pfizer Inc. (New York, NY) See Plans and Pricing
Aramchol See Plans and Pricing Monocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP) See Plans and Pricing
Aramchol See Plans and Pricing Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Aramchol

Drugname Country Document Number Estimated Expiration Related US Patent
Aramchol Argentina AR108838 2036-06-21 See Plans and Pricing
Aramchol Australia AU2017281439 2036-06-21 See Plans and Pricing
Aramchol Australia AU2021209334 2036-06-21 See Plans and Pricing
Aramchol Brazil BR112018076558 2036-06-21 See Plans and Pricing
Aramchol Canada CA3029202 2036-06-21 See Plans and Pricing
Aramchol Chile CL2018003708 2036-06-21 See Plans and Pricing
Aramchol China CN109963843 2036-06-21 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Harvard Business School
Baxter
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.